For budding biotech businesses, securing capital can be a significant hurdle. Hiring a permanent Chief Financial Manager is frequently prohibitively costly, especially when profits are restricted. A interim CFO https://sahilmwix445390.blog5.net/92493888/fractional-cfo-a-biotech-funding-lifeline